They reported a correlation between exo-PD-L1 levels and IHC PD-L1 status and exo-PD-L1 levels and lymph node metastasis, indicating that their identification might forecast the effectiveness of ICIs treatment in lung cancer patients [259]. This evidence concerns the gene CD274 and lung cancer.